IMXI International Money Express

Filed: 4 Nov 20, 4:30pm

Washington, D.C. 20549


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 4, 2020

(Exact name of registrant as specified in charter)

(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

9480 South Dixie Highway, Miami, Florida
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (305) 671-8000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock ($0.0001 par value)IMXIThe Nasdaq Capital Market

Item 8.01.Other Events.

As previously disclosed, on September 30, 2020, International Money Express, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with the selling stockholders named therein (the “Selling Stockholders”) and Credit Suisse Securities (USA) LLC, as representative of the several underwriters named therein (the “Underwriters”), relating to the underwritten public offering (“Offering”) of 4,925,000 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a price to the public of $13.50 per share. Certain of the Selling Stockholders also granted the Underwriters a 30-day option (the “Option”) to purchase up to 738,750 additional shares (the “Option Shares”) of Common Stock at the same price as the initial shares sold to the Underwriters.

As a result of the exercise by the Underwriters of the Option in full, on November 4, 2020, the sale of all of the Option Shares was completed.  The applicable Selling Stockholders received all of the net proceeds from the sale of the Option Shares.  The Company did not receive any proceeds from the sale of the Option Shares, but will bear certain costs associated with the sale of the Option Shares, other than underwriting discounts and commissions.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated:  November 4, 2020By:/s/ Tony Lauro II
 Name:Tony Lauro II
 Title:Chief Financial Officer